[EN] IL4I1 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS D'IL4I1 ET PROCÉDÉS D'UTILISATION
申请人:MERCK SHARP & DOHME
公开号:WO2021226003A1
公开(公告)日:2021-11-11
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as IL4I1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for IL4I1-related diseases.
本文描述了化合物I的结构或其药用盐。化合物I作为IL4I1抑制剂,可用于预防、治疗或作为IL4I1相关疾病的治疗剂。